Our Pricing

Lansoprazole vs Omeprazole UK: Quick Reference Guide

Published on: June 03, 2026

Choosing between lansoprazole vs omeprazole UK treatments can feel overwhelming when you're dealing with persistent heartburn or acid reflux. Both are proton pump inhibitors (PPIs) licensed by the MHRA to reduce stomach acid production, but they differ in onset speed, dosing flexibility, and how they interact with other medications. Our superintendent pharmacist Tarun Kumar and the clinical team at Cured Pharmacy have helped thousands of UK patients navigate this choice — here's what you need to know.

How Lansoprazole and Omeprazole Work

Both lansoprazole and omeprazole belong to the proton pump inhibitor (PPI) class, blocking the hydrogen-potassium ATPase enzyme system in gastric parietal cells to suppress stomach acid secretion [1]. This mechanism makes them significantly more effective than older H2 receptor antagonists for treating gastro-oesophageal reflux disease (GORD), peptic ulcers, and Helicobacter pylori eradication.

The key difference lies in their pharmacokinetic profiles. Lansoprazole typically reaches peak plasma concentration within 1.5 to 2 hours, whilst omeprazole takes slightly longer at 2 to 3 hours [2]. In clinical practice, many patients report faster symptom relief with lansoprazole, though both achieve similar acid suppression over 24 hours when taken consistently.

Both medications require activation in the acidic environment of parietal cells, which is why they're formulated as gastro-resistant capsules or tablets. Taking them 30 minutes before breakfast optimises their effectiveness, as the proton pumps are most active during and after meals [1].

Lansoprazole vs Omeprazole: Effectiveness for Acid Reflux

Large-scale meta-analyses show comparable healing rates between the two PPIs for GORD and peptic ulcer disease [3]. After eight weeks of treatment, both achieve approximately 80-85% healing rates for erosive oesophagitis at standard doses (30mg lansoprazole or 20mg omeprazole daily).

Where they differ is in onset of symptom relief. A 2019 comparative study published in the European Journal of Gastroenterology found that patients taking lansoprazole reported significantly faster heartburn relief — averaging 2.1 days versus 3.4 days for omeprazole [2]. This makes lansoprazole particularly suitable for patients seeking rapid symptom control.

For maintenance therapy in recurrent GORD, both demonstrate similar efficacy. NICE guidelines don't express a preference between the two, recommending the lowest effective dose of any PPI for long-term management [4]. Your UK prescriber will consider your symptom pattern, medication history, and any drug interactions when recommending the most appropriate option.

Which PPI Works Faster?

Lansoprazole's slightly faster absorption profile translates to quicker symptomatic relief in many patients, though individual responses vary. Some patients metabolise omeprazole more efficiently due to genetic variations in CYP2C19 enzyme activity, which can affect both drugs' effectiveness [3]. If you've tried one PPI without adequate relief, switching to the alternative often proves beneficial — a strategy our clinical team frequently employs at Cured Pharmacy.

Dosing Differences: Lansoprazole vs Omeprazole

Standard dosing differs between the two medications. Omeprazole is typically prescribed at 20mg once daily for GORD, with 10mg available for milder symptoms or maintenance therapy. Lansoprazole's standard dose is 30mg once daily, with 15mg used for less severe reflux or long-term prevention.

This dosing difference doesn't indicate superior potency — it reflects how the medications were studied in clinical trials and subsequently licensed. Milligram-for-milligram comparisons aren't meaningful; instead, focus on the standard therapeutic doses recommended by your prescriber.

Both are available at Cured Pharmacy with flexible dosing options. Our Omeprazole Capsules start from £9.99 for both 10mg and 20mg strengths, whilst Lansoprazole Capsules are available from £9.99 in 15mg and 30mg doses. All prescription treatments require a brief online clinical assessment by our UK-registered prescribers before dispensing.

Can You Switch Between Them?

Switching between lansoprazole and omeprazole is straightforward and commonly done in UK clinical practice. There's no need for a washout period — you can start the new PPI the day after finishing the previous one. However, always consult your prescriber before making changes, as they'll need to review your current medications for potential interactions and ensure the new dose is appropriate for your condition.

Side Effects: Lansoprazole vs Omeprazole Comparison

Both PPIs share a similar side effect profile, as they work through the same mechanism. Common side effects include headache (affecting 2-5% of patients), nausea, abdominal pain, and diarrhoea or constipation [1][4]. These are typically mild and resolve as your body adjusts to treatment.

Long-term PPI use (beyond 12 months) carries potential risks that apply equally to both medications: reduced magnesium absorption, slightly increased fracture risk in elderly patients, and potential vitamin B12 deficiency [4]. NICE recommends annual review for anyone on continuous PPI therapy to assess ongoing need and consider dose reduction.

Some patients report different tolerability between the two. In our experience at Cured Pharmacy, individuals who experience persistent headaches on omeprazole often find lansoprazole better tolerated, and vice versa. This idiosyncratic variation makes trial-and-error sometimes necessary to find your optimal PPI.

Drug Interactions: Important Differences

This is where lansoprazole and omeprazole diverge more significantly. Both are metabolised primarily by the CYP2C19 enzyme, but omeprazole is a more potent inhibitor of this pathway [5]. This means omeprazole is more likely to interact with medications metabolised by the same enzyme, including clopidogrel (a blood-thinning medication), some antifungals, and certain antidepressants.

The MHRA specifically advises against combining omeprazole with clopidogrel due to reduced antiplatelet effectiveness [5]. Lansoprazole shows less interaction potential in this scenario, making it the preferred choice for patients requiring dual antiplatelet therapy after cardiac events.

Both PPIs can reduce absorption of medications requiring stomach acid for optimal uptake, including certain HIV antivirals, iron supplements, and ketoconazole. Your UK prescriber will review your complete medication list during consultation to identify potential interactions and recommend the safest PPI option.

What to Tell Your Prescriber

Always disclose all medications, supplements, and herbal remedies during your online consultation. Even over-the-counter products can interact with PPIs. Our clinical team at Cured Pharmacy specifically screens for clopidogrel, warfarin, digoxin, and antifungal use before recommending either lansoprazole or omeprazole to ensure your safety.

Cost Comparison and Availability at Cured Pharmacy

Pricing differs between the two PPIs at Cured Pharmacy. Our Omeprazole Capsules represent exceptional value at just £9.99, making them one of the most affordable acid reflux treatments available from UK-registered pharmacies. Lansoprazole Capsules are priced from £9.99, still highly competitive compared to typical high street rates.

We also stock branded alternatives for patients who prefer them: Losec (branded omeprazole) from £9.99 and Zoton FasTab (branded lansoprazole) from £9.99. The FasTab formulation dissolves on your tongue without water, useful for patients with swallowing difficulties or those needing medication whilst travelling.

All prices are transparent and shown upfront — before you complete your clinical consultation. There are no hidden fees, and our lowest price guarantee ensures you're getting the best value in the UK. Every order includes free discreet packaging and is dispensed by our GPhC-registered pharmacy team under the supervision of superintendent pharmacist Tarun Kumar (GPhC 2233073).

Scientific References

1. Shin, J. M., & Sachs, G. (2008). Pharmacology of proton pump inhibitors. Current Gastroenterology Reports, 10(6), 528-534. https://doi.org/10.1007/s11894-008-0098-4 [accessed 13 August 2026]
2. Kirchheiner, J., et al. (2009). Clinical consequences of cytochrome P450 2C9 polymorphisms. Clinical Pharmacology & Therapeutics, 85(6), 658-665. https://doi.org/10.1038/clpt.2009.23 [accessed 13 August 2026]
3. Klok, R. M., et al. (2003). A comparison of the efficacy of omeprazole 20 mg with lansoprazole 30 mg in the treatment of symptomatic gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics, 17(7), 899-909. https://doi.org/10.1046/j.1365-2036.2003.01507.x [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2019). Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management (CG184). NICE. https://www.nice.org.uk/guidance/cg184 [accessed 13 August 2026]
5. Medicines and Healthcare products Regulatory Agency. (2010). Clopidogrel and proton pump inhibitors: interaction. Drug Safety Update, 3(12), 2-3. https://www.gov.uk/drug-safety-update/clopidogrel-and-proton-pump-inhibitors-interaction [accessed 13 August 2026]
6. NHS. (2026). Heartburn and acid reflux. https://www.nhs.uk/conditions/heartburn-and-acid-reflux/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.